Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis.

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Josef Veselka

Motol University Hospital, Prague (Czechia)

4 More presentations in this session

Presentation thumbnail

State of the Art in the treatment of hypertrophic cardiomyopathy

Professor I. Olivotto (Florence, IT)

Presentation thumbnail

Earlier surgical myectomy vs. waiting for a Class I indication is associated with improved long-term survival in symptomatic hypertrophic obstructive cardiomyopathy patients

Doctor M. Desai (Cleveland, US)

Abstract Slides Video

Presentation thumbnail

A novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)

Doctor G. Norrish (London, GB)

Abstract Slides Video

Presentation thumbnail

Long-term safety and effectiveness of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients (pts): update from PIONEER open-label extension (PIONEER-OLE) study

Professor A. Wang (Durham, US)

Abstract Slides Video

Access the full session

Session thumbnail

Novel therapeutic targets in hypertrophic cardiomyopathy

The Event

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources